Features of Regional Perfusion of Lung Consolidation

Overview

The aim of this study is to evaluate the potential usefulness of lung ultrasound to assess the size and perfusion of consolidation and explore their relationships with clinical outcome.

Full Title of Study: “Evaluation of Regional Perfusion of Lung Consolidation Upon Lung Ultrasonography”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2023

Detailed Description

Lung consolidation is one of the most causes of hypoxia in intensive care unit(ICU) settings. A quantitative measurement of consolidation would be extremely benefit for the clinical management in hypoxemia, both as an index of severity and to predict outcomes.In order to quantify the lung consolidation and its effect on clinical outcomes, a simple and quantitative scoring system of the size and perfusion of lung consolidation was proposed by lung ultrasound. Subjects with respiratory failure and lung consolidation proved by chest imaging underwent lung ultrasound examination. The size of consolidation and the richness of blood flow was computed upon lung ultrasound. The sensitivity, specificity and accuracy of the scoring system were calculated and compared to evaluate the diagnostic efficacy.

Interventions

  • Diagnostic Test: Ultrasound
    • Each patient underwent ultrasound after admission of ICU.

Arms, Groups and Cohorts

  • the consolidation perfusion/the consolidation size
    • Patients with respiratory failure and lung consolidation proved by chest imaging underwent lung ultrasound to evaluate the regional perfusion and the size of consolidation.

Clinical Trial Outcome Measures

Primary Measures

  • consolidation area index
    • Time Frame: through study completion, an average of 2 year
    • The volume of consolidation was measured by consolidation area index (CAI) which is calculated from two-dimensional measures, namely the product of the core distance (from the bottom to the top of the screen) and the longitudinal distance (from the left to the right of the screen).
  • blood flow score
    • Time Frame: through study completion, an average of 2 year
    • A semi-quantified scoring system based on the richness of flow signals was established. It identifies four progressive steps of blood signals, each corresponding to a score: no pulsatile blood flow-score 0; sparse dot-like blood flow-score 1; pronounced curvilinear vascularity-score 2; tree-like vascularity-score 3.

Participating in This Clinical Trial

Inclusion Criteria

1. Admission to ICU( 18yr<age<90yr); 2. Patients presented with acute respiratory failure; 3. Pulmonary consolidation by chest imaging (lung ultrasound, X ray or CT scan). Exclusion criteria:

1. Hemodynamic instability (i.e., severe hypotension with systolic arterial pressure<60mmHg despite fluid expansion and vasoactive support; systolic arterial pressure>180mmHg; uncontrolled cardiac arrhythmias); 2. Severe thoracic trauma; 3. Coronavirus disease 2019; 4. Pulmonary artery hypertension and pregnancy.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Peking Union Medical College Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Huaiwu He, MD, Principal Investigator, Peking Union Medical College Hospital
  • Overall Contact(s)
    • Na Wang, MD, 17810258960, wangna_pumch2017@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.